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Background: The impact of cardiac resynchronization therapy (CRT) on dispersion of repolarization is
controversial. This study aimed to determine whether CRT alters the QT interval and Tpeak–Tend
interval (Tpeak–end) and whether such changes relate to the risk of developing a major arrhythmic
event (MAE).
Methods: Data from 67 patients (49 men; age 71710 years) who underwent CRT device placement
were analyzed retrospectively. Patients had NYHA class III or IV heart failure. Mean left ventricular
ejection fraction was 2579%. The electrocardiogram was recorded at baseline and during follow-up
after implantation (3 days, 7 days, 1 month, and 2 months).
Results: After 29-months of follow-up, 11 patients had experienced MAEs. QT interval and Tpeak–end
did not change signiﬁcantly immediately after CRT. However, 3 days after CRT, Tpeak–end in patients
with MAE was signiﬁcantly increased when compared with patients without MAE (po0.05). We
divided patients into 2 groups according to the change in Tpeak–end at 3 days (increased Tpeak–end
group, n¼27; decreased Tpeak–end group, n¼40). The increased Tpeak–end group demonstrated a
signiﬁcant increase in MAEs (po0.05).
Conclusions: Increased Tpeak–end at 3 days after CRT was associated with a signiﬁcant increase in
MAEs. This could be a useful predictor of ventricular proarrhythmia.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Cardiac resynchronization therapy (CRT) has been proven to
decrease morbidity and overall mortality in heart failure patients
with cardiac dyssynchrony [1–5]. While several randomized
studies (COMPANION study, CARE-HF study) have demonstrated
that biventricular pacing results in an improvement of interven-
tricular synchronization, systolic function, exercise tolerance, and
quality of life [1–4], the effect of this therapy on the incidence of
ventricular arrhythmias is less clear. Several studies have sug-
gested that CRT suppresses the incidence of major arrhythmic
events (MAEs), citing reduced wall stress (as a result of reverse
remodeling) and decreased repolarization dispersion (as a result of
dual depolarization wavefronts) as potential mechanisms [6–8].
Other studies, however, have demonstrated a proarrhythmicrt Rhythm Society. Published by E
ic event; QTd, QT dispersion;
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rtment of Medicine, Showa
agawa-ku, Tokyo 142-8666,
oshi).potential [9–13]. It remains unclear why certain rare patients
develop MAEs after CRT therapy. Recent reports [10–12] suggest
that left ventricular (LV) epicardial pacing can be proarrhythmic,
leading to polymorphic ventricular tachycardia (VT) by reversal of
the normal activation sequence, prolongation of the QT interval,
and creation of transmural dispersion of repolarization (TDR). LV
epicardial pacing reverses the natural activation sequence from
endocardium to epicardium. This reduces the repolarization time
of the already short epicardial action potentials, thereby increas-
ing repolarization time differences compared with the longer
underlying action potentials of the midmyocardial and endocar-
dial layers. Thus, TDR may contribute to ventricular arrhythmias
[11]. We hypothesize that the increase of Tpeak–end after CRT
may be a good predictor of ventricular tachyarrhythmia if it
reﬂects transmural dispersion in the LV.2. Methods
2.1. Patients and study design
We retrospectively analyzed data from 67 consecutive patients
who had undergone successful CRT implantation (CRT-pacemakerlsevier B.V. All rights reserved.
Table 1
Characteristics of the overall study population (n¼67).
Gender (male/female) 49/18
Age (years) 71710
Ejection fraction (%) 2579
New York Heart Association functional class
III 62 (93%)
IV 5 (7%)
Ischemic heart disease 28 (42%)
Cardiomyopathy 35 (52%)
Valvular heart disease 4 (6%)
ACE-I/ARB 47 (70%)
Beta-blocker 42 (63%)
Digoxin 14 (21%)
Amiodarone 12 (18%)
Statin 26 (39%)
Device
CRT-P 26 (39%)
CRT-D 41 (61%)
Upgrade PM-CRT-P 8
PM-CRT-D 6
ICD-CRT-D 4
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Fig. 1. Kaplan–Meier survival curve of freedom from ﬁrst ventricular arrhythmic
event after CRT device implantation.
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between July 2001 and November 2009. In all cases, an LV lead
was implanted in the coronary sinus in order to achieve perma-
nent epicardial stimulation from a lateral or posterolateral vein.
The right ventricular lead was implanted in the apex in all
patients. The electrocardiogram (ECG) was assessed during the
intrinsic rhythm at baseline and during biventricular pacing at
follow-up (3 days, 7 days, 1 month, and 2 months). Immediately
after CRT device implantation, an ECG was recorded during
sinus rhythm (SR), right ventricular endocardial pacing (RVP),
left ventricular epicardial pacing (LVP), and biventricular pacing
(BiVP). Two different experts, who were blinded to follow-up of
the patients, manually analyzed all ECGs. For each ECG, the
following parameters proposed to measure dispersion of repolar-
ization were analyzed: heart rate (HR), QRS duration, QT interval,
QT interval corrected for HR (QTc), QT dispersion (QTd), and
Tpeak–Tend interval (Tpeak–end). For the purposes of this study,
MAE was deﬁned as sustained ventricular tachycardia and/or
ventricular ﬁbrillation.
2.2. ECG measurements
QT interval was measured from the beginning of the QRS
complex to the end of the T wave in all leads, deﬁned as the
tangent to the downslope of the T wave and the isoelectric line.
QTc was calculated using the Bazett formula. QT dispersion was
deﬁned as the difference between the maximum and the mini-
mum QT interval of all leads. Tpeak–end interval was deﬁned as
the interval from the maximum T wave amplitude to the end of
the T wave. The end of the T wave was set at the point where the
tangent to the steepest portion of the terminal part of the T wave
crossed the isoelectric line. Tpeak–end was measured in all
6 precordial leads (V1–V6) and then averaged.
2.3. Statistical analysis
Data are expressed as means7standard deviation. The data
were compared using Student’s t test for paired or unpaired
samples; chi-square test and Kaplan–Meier survival techniques
were used to assess time to occurrence of MAE. A p-value of
o0.05 was considered statistically signiﬁcant.3. Results
3.1. Baseline characteristics
Overall population characteristics are given in Table 1. Patients
had symptoms of NYHA class III (n¼62) or IV (n¼5) heart failure
despite optimal medical treatment, as a result of ischemic heart
disease (n¼28), cardiomyopathy (n¼35), or valvular heart dis-
ease (n¼4). Patients maintained chronic medications, including
angiotensin converting-enzyme or angiotensin receptor blocker,
diuretics, digoxin, and beta-blockers until the time of CRT
device implantation. Twelve of 67 patients had been taking
amiodarone doses of 200–400 mg once a day. Mean left ventri-
cular ejection fraction was 2579%. Eighteen patients were
upgraded to CRT (dual-chamber pacemaker to CRT-P, n¼8;
to CRT-D, n¼6; implantable cardioverter-deﬁbrillator (ICD) to
CRT-D, n¼4). During a mean follow-up period of 29723 months,
11 patients experienced MAEs, and this occurred comparatively
early after CRT implantation. The Kaplan–Meier survival curve for
freedom from ﬁrst ventricular arrhythmic event after CRT implan-
tation is shown in Fig. 1. MAE occurred at a mean of 376 days
(range 0–1534 days) after implantation of CRT. MAE occurred
within 1 year of CRT implantation in 8 patients, and within2 months in 4 of these patients. The demographic and clinical
data for the 67 patients according to presence or absence of MAE
are shown in Table 2. With the exception of secondary prevention,
no signiﬁcant difference in baseline characteristics was observed
in the 2 patient groups.
3.2. ECG parameters before and immediately after CRT implantation
ECG parameters before and immediately after CRT in the MAE
and no-MAE groups are listed in Table 3. Comparison of the
2 groups revealed no differences in baseline HR, QRS duration, QT
interval, QTc, QTd, or Tpeak–end. Comparison of the MAE and no-
MAE groups immediately after CRT revealed no differences in HR,
QRS duration, QT interval, QTc, QTd, or Tpeak–end.
3.3. Inﬂuence of pacing site on ECG parameters
ECG recording was performed during SR, RVP, LVP, and BiVP
immediately after implantation. The effects of different pacing modes
on QRS duration, QT interval, QTd, and Tpeak–end are shown in Fig. 2.
RV and LV pacing signiﬁcantly increased QRS duration (po0.05) as
compared to intrinsic SR, whereas BiVP signiﬁcantly decreased QRS
duration (po0.05) (QRS duration: SR 156728ms, RVP 188724ms,
LVP 181729ms, and BiVP 140717ms). QT interval during RVP and
LVP was signiﬁcantly increased (po0.05) as compared to intrinsic
Table 3
ECG parameters before and immediately after CRT device implantation according
to presence or absence of major arrhythmic events.
MAE group
(n¼11)
No-MAE group
(n¼56)
P
value
Baseline
HR (bpm) 75717 76714 0.847
QRS duration (ms) 156738 159729 0.704
QT (ms) 444755 433758 0.567
QTc (ms) 501743 499742 0.867
QT dispersion (ms) 52717 50718 0.704
Tpeak–end (ms) 110715 104715 0.262
Tpeak–end dispersion (ms) 29711 26711 0.475
Immediately after CRT implantation
HR (bpm) 78722 77717 0.867
QRS duration (ms) 146718 138716 0.179
QT (ms) 449766 450758 0.940
QTc (ms) 522735 517735 0.676
QT dispersion (ms) 26717 28712 0.70.5
Tpeak–end (ms) 10479 106713 0.590
Tpeak–end dispersion (ms) 1676 1577 0.556
Table 2
Demographic and clinical data for the 67 patients according to presence or
absence of major arrhythmic events.
MAE group
(n¼11)
No-MAE group
(n¼56)
P
value
Gender (male/female) 9/2 40/16 0.477
Age (years) 67713 70710 0.331
Ejection fraction (%) 2578 2479 0.827
NYHA III 10 52 0.822
IV 1 4
Ischemic heart disease 5 (45%) 23 (41%) 0.74
Cardiomyopathy 6 (54%) 29 (52%)
Valvular heart disease 0 (0%) 4 (8%)
Secondary prevention 6 (54%) 6 (11%) 0.0005
Device CRT-P 2 24 0.124
CRT-D 9 32
HF decompensation after CRT 6 (54%) 19 (34%) 0.196
ARB/ACE-I 6 (55%) 41 (73%) 0.21
Beta-blocker 7 (64%) 35 (63%) 0.94
Digoxin 3 (27%) 11 (20%) 0.56
Amiodarone 4 (36%) 8 (14%) 0.08
Statin 5 (45%) 21 (38%) 0.62
VF detection setting (bpm) 19377 193713 0.96
VT detection setting (bpm) 169718 159718 0.23
MAE¼major arrhythmic event.
HF¼heart failure.
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SR 451759ms, RVP 475751ms, LVP 475746ms, and BiVP
451749ms). QTc during RVP and LVP was signiﬁcantly increased
(po0.05) as compared to intrinsic SR, whereas it was not signiﬁ-
cantly changed by BiVP (QTc: SR 501742ms, RVP 569746ms, LVP
580751ms, and BiVP 521735ms). When compared with SR,
none of the pacing modes had a signiﬁcant effect on QTd (QTd: SR
28713ms, RVP 24712ms, LVP 30716ms, and BiVP 28714ms).
Tpeak–end interval during RV and LV pacing increased signiﬁcantly
(po0.05) as compared to intrinsic SR, whereas it was not changed
signiﬁcantly by BiVP (Tpeak–end: SR 109713ms, RVP 118713ms,
LVP 118713ms, and BiVP 106713ms).
3.4. Changes in ECG parameters after CRT implantation
No changes were seen in QRS duration, QT interval, QTc, or QTd
during 2 months of follow-up after CRT implantation. Moreover,these parameters did not vary signiﬁcantly according to MAE status.
However, CRT led to an overall signiﬁcant reduction in Tpeak–end,
averaging 1.9 ms after 3 days (p¼ns), 6.2 ms after 7 days
(po0.05), 8.6 ms after 1 month (po0.05), and 5.0 ms after
2 months (po0.05). Tpeak–end in the MAE group increased
signiﬁcantly compared with that in the no-MAE group at 3 days
post-implantation (po0.05) (Fig. 3).
3.5. Potential proarrhythmic effect of CRT
To determine whether pacing-induced changes in Tpeak–end
were related to proarrhythmic potential in patients undergoing
CRT, we divided the subjects into 2 groups according to the
change in Tpeak–end from immediately after CRT implantation
to 3 days post-implantation (increased Tpeak–end group, n¼27;
decreased Tpeak–end group, n¼40). Differences in survival
curves were observed when patients were dichotomized accord-
ing to whether Tpeak–end increased or decreased in relation
to baseline values at 3 days following implantation (Fig. 4). The
increased Tpeak–end group demonstrated a signiﬁcant increase
in MAEs (po0.05). We also calculated the change in Tpeak–end
between before and immediately after CRT implantation
(increased Tpeak–end group, n¼33; decreased Tpeak–end
group, n¼34), and there was no signiﬁcant difference in MAEs
between these 2 groups.4. Discussion
4.1. Main ﬁndings
In our study, secondary prevention was an independent pre-
dictor of MAE. Most of the patients upgraded to CRT-D already
had an ICD for secondary prevention, indicating a baseline
increased risk for ventricular arrhythmias.
In terms of parameters at baseline and immediately after CRT,
QRS duration, QT interval, QTc, QTd, and Tpeak–end were not
predictors of MAE. We found that CRT led to an overall reduction
in Tpeak–end interval. However, when patients were stratiﬁed by
MAE status, Tpeak–end was signiﬁcantly increased 3 days after
implantation in the MAE group when compared with that in the
no-MAE group. Differences in survival curves were observed
when patients were dichotomized according to whether Tpeak–
end increased or decreased in relation to baseline values at 3 days
following implantation. An increase in Tpeak–end above baseline
at 3 days conferred the greatest risk of future MAE.
4.2. Previous studies
In a recent study, it was suggested that biventricular pacing
has potential detrimental effects on ventricular repolarization.
Some reports suggest that LV epicardial pacing can be proar-
rhythmic, leading to polymorphic VT by reversal of the normal
activation sequence, prolongation of the QT interval, and creation
of TDR [11–21]. Experimentally, Medina-Ravell et al. found a
potentially harmful effect of cardiac resynchronization therapy on
ventricular repolarization in ventricular wedge preparations [11].
They determined that LV epicardial and biventricular pacing
prolonged QT and QT dispersion and increased TDR, which could
possibly lead to the development of torsades de pointes in heart
failure patients undergoing CRT [11]. Using mathematical models
and canine wedge preparations, Fish et al. showed a signiﬁcant
increase in TDR and the QT interval when pacing was shifted from
the endocardium to the epicardium [12].
Recent studies have also suggested that Tpeak–end may be a
useful index of transmural dispersion, and thus may be prognostic
Fig. 2. Changes in ECG parameters with different pacing sites. (A) Changes in QRS duration, (B) QT interval, (C) QTc, (D) QT dispersion, (E) Tpeak–end interval during sinus
rhythm (SR), right ventricular (RV), left ventricular (LV), and biventricular (BiV) pacing. Results are expressed as median7SD (n¼po0.05, with respect to the intrinsic
QRST complex).
Fig. 3. (A) Changes in Tpeak–end interval after CRT device implantation. CRT led to an overall reduction in Tpeak–end interval. (B) Changes in Tpeak–end interval after CRT
device implantation according to presence or absence of MAE. Tpeak–end was signiﬁcantly increased in the MAE group when compared with that in the no-MAE group 3
days after implantation. Results are expressed as median7SD (n¼po0.05). MAE¼major arrhythmic event.
Fig. 4. Kaplan–Meier survival curves according to change in Tpeak–end (A) from immediately after CRT device implantation to 3 days of follow-up; (B) baseline to
immediately after CRT device implantation.
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TDR more accurately than QTc and QTd [22]. Lellouche et al.
showed that, in patients with left bundle branch block or narrow
QRS at baseline, CRT induced an increase of Tpeak–end without
signiﬁcant changes in QT dispersion or Tpeak–end dispersion.
Immediate post-CRT Tpeak–end was the only independent pre-
dictor for ICD therapy after a 1-year follow-up [23]. Shimizu et al.
showed that Tpeak–end, rather than QT dispersion, was a good
clinical predictor for sudden cardiac death and VT in patients with
hypertrophic cardiomyopathy [24].
However, other clinical studies have found the opposite results
in HF patients. Berger et al. showed that the Tpeak–end interval
was signiﬁcantly increased during RVP and LVP, but signiﬁcantly
decreased during BiVP [16]. Chalil et al. retrospectively examined
the prognostic value of these parameters (including Tpeak–end)
in predicting sudden cardiac death in CRT patients. Changes in the
Tpeak–end interval, however, failed to emerge as a signiﬁcant
predictor of MAE. They also suggested that DQT dispersion was
the best independent predictor of sudden cardiac death [25].
CRT has a differential effect on the Tpeak–end interval, and this is
related to the development of MAE. This raises the possibility that
BiVP has differential effects on the arrhythmogenic substrate, i.e., it
is antiarrhythmic in some and arrhythmogenic in others.
4.3. Changes in Tpeak–end interval after CRT device implantation
In the present study, CRT led to an overall signiﬁcant reduction
in Tpeak–end by 7 days post-CRT implantation (po0.05). Three
days after CRT, Tpeak–end in patients who developed MAEs was
signiﬁcantly increased when compared with patients without
MAE (po0.05). These T wave changes during the ﬁrst 3–7 days
after CRT implantation might represent cardiac memory (CM).
Recently, Wecke et al., in a human pacing model, showed that
CM developed and reached steady state within 1 week of right
ventricular endocardial pacing, was preserved in proportion to
delivered ventricular pacing, and completely resolved within
1 month in its absence [26]. Padeletti et al. investigated the
development of CM during CRT through vectorcardiography. CRT
induced signiﬁcant changes in the T vector magnitude and
elevation after resumption of spontaneous ventricular activation
observed 7 days after implantation [27].
These T wave changes during the ﬁrst 7 days after CRT were
similar in our study, indicating that CM might be related to the
occurrence of MAEs. The effects of biventricular pacing on CM
induction have not been fully investigated. Further studies are
needed to resolve these issues.
4.4. Predictors of MAE in CRT
Little is known about which factors might modulate the
arrhythmogenic substrate in patients undergoing CRT. In our
study, ECG parameters measured before and immediately after
CRT were not predictive of MAE. However, we found that
increased Tpeak–end 3 days after CRT implantation did predict
MAEs. CRT has a differential effect on Tpeak–end, with some
patients exhibiting an increase above values measured immedi-
ately after CRT. Such an increase in Tpeak–end may carry a risk of
arrhythmic events. If our clinical data are conﬁrmed by larger
prospective studies, Tpeak–end measurements from baseline to
3 days post-CRT implantation should be considered for future
management of CRT patients.
4.5. Study limitations
This study has several limitations. First, it is small and
observational. A relatively long follow-up period, however, hasyielded a sufﬁcient number of MAEs to achieve statistical sig-
niﬁcance in survival analyses. Second, we measured the QT and
Tpeak–end intervals manually since we did not have an auto-
mated measurement system for these variables, which may have
resulted in intraobserver and interobserver variability, particu-
larly for the estimation of T-wave offset. However, the manual
measurements did not have a signiﬁcant effect on our results, as
shown by the small intraobserver variability. Third, no prospec-
tive evaluation of arrhythmogenic events during different stimu-
lation modes was performed in our study. Further studies are
needed to address these issues.5. Conclusion
We have shown that patients who exhibit an increase in
Tpeak–end at 3 days after CRT may be at higher risk of MAEs
compared with those who exhibit a decrease. Further prospective
studies are needed to determine whether evaluation of Tpeak–
end at the time of biventricular pacemaker implantation can be
used for risk-stratiﬁcation of patients regarding the preferential
use of CRT with ICD backup.Conﬂict of interest
There is no conﬂict of interest.
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